Infantile spasms in down syndrome: Rescue by knockdown of the GIRK2 channel

Ann Neurol. 2016 Oct;80(4):511-21. doi: 10.1002/ana.24749. Epub 2016 Aug 13.

Abstract

Objective: The Ts65Dn (Ts) mouse model of Down syndrome (DS) is exquisitely sensitive to an infantile spasms phenotype induced by γ-aminobutyric acidB receptor (GABAB R) agonists. The Ts mouse contains the core genomic triplication of the DS critical region, which includes 3 copies of the Kcnj6 gene that encodes the GABAB R-coupled G protein-coupled inward rectifying potassium channel subunit 2 (GIRK2) channel. We test the hypothesis that GIRK2 is necessary for the GABAB R agonist-induced infantile spasms phenotype in Ts.

Methods: We assessed the result of either genetic or pharmacological knockdown of the GIRK2 channel in Ts brain upon the GABAB R agonist-induced infantile spasms phenotype in the Ts mouse model of DS. As well, we examined GABAB R currents in hippocampal neurons prepared from GIRK2-trisomic Ts control mice and GIRK2-disomic Ts mice in which Kcnj6 had been genetically knocked down from 3 to 2 copies.

Results: The reduction of the copy number of Kcnj6 in Ts mice rescued the GABAB R agonist-induced infantile spasms phenotype. There was an increase in GABAB R-mediated GIRK2 currents in GIRK2-trisomic Ts mouse hippocampal neurons, which were normalized in the GIRK2-disomic Ts mice. Similarly, pharmacological knockdown of the GIRK2 channel in Ts brain using the GIRK antagonist tertiapin-Q also rescued the GABAB R agonist-induced infantile spasms phenotype in Ts mutants.

Interpretation: The GABAB R-coupled GIRK2 channel is necessary for the GABAB R agonist-induced infantile spasms phenotype in the Ts mouse and may represent a novel therapeutic target for the treatment of infantile spasms in DS. Ann Neurol 2016;80:511-521.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bee Venoms / pharmacology
  • Disease Models, Animal
  • Down Syndrome
  • Female
  • G Protein-Coupled Inwardly-Rectifying Potassium Channels / antagonists & inhibitors
  • G Protein-Coupled Inwardly-Rectifying Potassium Channels / drug effects
  • G Protein-Coupled Inwardly-Rectifying Potassium Channels / genetics
  • G Protein-Coupled Inwardly-Rectifying Potassium Channels / metabolism*
  • GABA-B Receptor Agonists / pharmacology*
  • Hippocampus / metabolism
  • Hippocampus / physiopathology
  • Humans
  • Infant, Newborn
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Neurons / metabolism
  • Neurons / physiology
  • Phenotype
  • Potassium Channel Blockers / pharmacology*
  • Receptors, GABA-B / metabolism*
  • Spasms, Infantile / chemically induced
  • Spasms, Infantile / genetics
  • Spasms, Infantile / metabolism*
  • Synaptic Potentials / physiology
  • Trisomy

Substances

  • Bee Venoms
  • G Protein-Coupled Inwardly-Rectifying Potassium Channels
  • GABA-B Receptor Agonists
  • Kcnj6 protein, mouse
  • Potassium Channel Blockers
  • Receptors, GABA-B
  • tertiapin

Grants and funding